PSIP1 and cancer: Our results highlight the need for analyzing simultaneously LEDGF/p75 mRNA and protein expression in the same tumor samples in future studies aimed at investigating the role of this pro-survival protein in the progression of a specific cancer type, and its potential value as a biomarker for tumor aggressiveness or chemoresistance.